Why is Gufic BioScience falling/rising?

As of 08-Jul, Gufic BioSciences Ltd is experiencing a decline in its stock price, currently at 340.05, which reflects a decrease of 3.85 points or 1.12%. The stock has been on a downward trend, losing value for the last three consecutive days and showing a total decline of 3.02% during this period. Additionally, Gufic BioSciences is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The company has reported a significant drop in net sales and has declared negative results for the last two consecutive quarters, contributing to a poor performance with a 24.94% decline year-to-date. Despite having a high return on capital employed (ROCE) of 24.34% and a low debt-to-EBITDA ratio, the stock's valuation appears expensive relative to its earnings, further pressuring its price.
In the broader market context, Gufic BioSciences has underperformed compared to the Sensex, which has shown a slight increase of 0.02% over the past week, while Gufic's stock has decreased by 3.97% in the same timeframe. The company's performance over the last year has also been disappointing, with a return of -6.12%, contrasting with the Sensex's gain of 4.69%. This underperformance is compounded by a significant drop in investor participation, as evidenced by a 66.28% decline in delivery volume compared to the 5-day average, indicating a lack of confidence among investors. Overall, the combination of negative financial results, declining sales, and poor market sentiment has led to the stock's current downward trajectory.